Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5–11 Years

There are limited data concerning the immunogenicity and reactogenicity of COVID-19 vaccines in children. A total of 110 children, 5–11 years old were vaccinated with two doses (with a 3-week interval between doses) of the Pfizer-BioNTech COVID-19 vaccine and were followed for 21, 90, and 180 days a...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Gili Joseph, Elisheva Klein, Yaniv Lustig, Yael Weiss-Ottolenghi, Keren Asraf, Victoria Indenbaum, Sharon Amit, Or Kriger, Mayan Gilboa, Yuval Levy, Itai M. Pessach, Yitshak Kreiss, Gili Regev-Yochay, Michal Stein
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI AG 2022-11-01
سلاسل:	Vaccines
الموضوعات:	COVID-19 antibodies children vaccines immunogenicity reactogenicity
الوصول للمادة أونلاين:	https://www.mdpi.com/2076-393X/10/11/1954
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!